SC 13G/A 1 0001.txt SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________ SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) (Amendment No. 4)/1/ NMT Medical, Inc. -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.001 per share -------------------------------------------------------------------------------- (Title of Class of Securities) 629294 10 9 ------------------------------ (CUSIP Number) December 31, 2000 -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [_] Rule 13d-1(c) [X] Rule 13d-1(d) /1/The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ------------------------- --------------------- CUSIP NO. 629294 10 9 13G Page 2 of 6 Pages -------------- ------------------------- --------------------- ------------------------------------------------------------------------------ NAME OF REPORTING PERSONS 1. I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS(ENTITIES ONLY) Fletcher Spaght, Inc. ID# 04-2950171 ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 2. (a) [_] (b) [_] ------------------------------------------------------------------------------ SEC USE ONLY 3. ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4. State of Delaware ------------------------------------------------------------------------------ SOLE VOTING POWER 5. 587,352 shares (includes 83,329 shares which Fletcher NUMBER OF Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6. OWNED BY 0 shares ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7. 587,352 shares (includes 83,329 shares which Fletcher REPORTING Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8. 0 shares ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9. 587,352 shares (includes 83,329 shares which Fletcher Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10. [_] Not Applicable ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11. 5.3% ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12. CO ------------------------------------------------------------------------------ *SEE INSTRUCTION BEFORE FILLING OUT! ------------------------- --------------------- CUSIP NO. 629294 10 9 13G Page 3 of 6 Pages ----------- ------------------------- --------------------- Item 1(a) Name of Issuer: --------- -------------- NMT Medical, Inc. Item 1(b) Address of Issuer's Principal Executive Office: --------- ---------------------------------------------- 27 Wormwood Street Boston, MA 02210 Item 2(a) Name of Person Filing: --------- --------------------- Fletcher Spaght, Inc. Item 2(b) Address of Principal Business Office or, if none, Residence: --------- ----------------------------------------------------------- 222 Berkeley Street Boston, MA 02116-3761 Item 2(c) Citizenship: --------- ----------- State of Delaware Item 2(d) Title of Class of Securities: --------- ---------------------------- Common Stock, $.001 par value per share Item 2(e) CUSIP Number: --------- ------------ 629294 10 9 Item 3 Description of Person Filing: ------ ---------------------------- Not applicable. Item 4 Ownership: ------ --------- (a) Amount Beneficially Owned: ------------------------- 587,352 shares (includes 83,329 shares which Fletcher Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) ------------------------- --------------------- CUSIP NO. 629294 10 9 13G Page 4 of 6 Pages ----------- ------------------------- --------------------- (b) Percent of Class: ---------------- 5.3% (c) Number of shares as to which person has: --------------------------------------- (i) sole power to vote or to direct the vote: 587,352 shares (includes 83,329 shares which Fletcher Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) (ii) shared power to vote or to direct the vote: 0 shares (iii) sole power to dispose or to direct the disposition of: 587,352 shares (includes 83,329 shares which Fletcher Spaght, Inc. has the right to acquire within 60 days after December 31, 2000) (iv) shared power to dispose or to direct the disposition of: 0 shares Item 5 Ownership of Five Percent or Less of a Class: ------ -------------------------------------------- Not applicable. Item 6 Ownership of More than Five Percent on Behalf of Another Person: ------ --------------------------------------------------------------- Not applicable. Item 7 Identification and Classification of the Subsidiary Which Acquired ------ ------------------------------------------------------------------- the Security Being Reported on by the Parent Holding Company or --------------------------------------------------------------- Control Person: -------------- Not applicable. ------------------------- --------------------- CUSIP NO. 629294 10 9 13G Page 5 of 6 Pages ----------- ------------------------- --------------------- Item 8 Identification and Classification of Members of the Group: ------ --------------------------------------------------------- Not applicable. Item 9 Notice of Dissolution of Group: ------ ------------------------------ Not applicable. Item 10 Certification: ------- ------------- Not applicable. ------------------------- --------------------- CUSIP NO. 629294 10 9 13G Page 6 of 6 Pages ----------- ------------------------- --------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. DATED: February 8, 2001 FLETCHER SPAGHT, INC. By: /s/ R. John Fletcher ------------------------------- Name: R. John Fletcher Title: Chief Executive Officer